Technical testing and analysis
BIONOR LABORATORIES AS
Revenue 2025
NOK 1.9m
Operating profit
NOK −57,000
Equity
NOK 408,000
Incorporated
1996
Share capital
NOK 100,000
Key figures · 2025
Current ratio
2.56
Equity ratio
64.1%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -2.9% | |
| Net margin (%%) | 3.9% | |
| Return on assets (%%) | -8.9% | |
| Likviditet | ||
| Current ratio | 2.56 | |
| Working capital | 358k | |
| Soliditet | ||
| Equity ratio (%%) | 64.1% | |
| Debt-to-equity ratio | 0.56 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.